Development of resistance in castration-resistant prostate cancer (CRPC) involves epigenetic pathways. A new study in PLOS Biology demonstrates that combined therapy targeting enhancer of zeste homolog 2 (EZH2) and histone deacetylases (HDACs) may sensitize CRPC to both epigenetic and standard therapies. Development of resistance in castration-resistant prostate cancer (CRPC) involves... https://safeersappliancers.shop/product-category/hoover-hbd-495d2e-integrated-washer-dryer-9-5kg-white-9kg-washing-capacity/